ing from 23 to 40 mg. per 24 hours; a fasting plasma 17-hydroxycorticoid level of 20 micrograms per 100 ml. (normal 4-30 micrograms) with no response to 25 mg. of ACTH intravenously over a 4-hour period on two separate occasions; and a urinary pregnanediol of 1.57 mg. per 24 hours (normal 0.3 mg.). The serum electrolytes were normal at this time. The urinary 17-ketosteroids were partially suppressed by the administration of 2 mg. of 9-a-fluorohydrocortisone daily for 10 days. In March, 1957, because of his symptomatology and the above laboratory findings he was treated with 37.5 mg. daily of cortisone with definite improvement in his symptoms and sense of well-being. The tentative diagnosis was adreno-genital syndrome although there was no history of precocious sexual development. He had noted severe acne since puberty and body hair was thought to be excessive.
In November, 1957, he had the beginning of another episode of fever which was still present when he was transferred from the University of Virginia Hospital to the YaleNew Haven Medical Center in January, 1958. During this attack his fever had reached 1040 F. in spite of as much as 125 mg. of cortisone acetate daily.
The patient appeared healthy except for a pulse of 120 and a moderate fever. The liver was palpable 4 centimeters below the right costal margin and a spleen tip could be felt. According to the history these findings had been present since 1932. Firm, discrete 0.5-1.0 cm. cervical and axillary lymph nodes were also palpable. During his hospitalization the patient had temperature spikes of 
METHODS

Plasma:
Blood was obtained from the first patient during the febrile state, and a second sample was studied 8 weeks later while he was afebrile and receiving 25 mg. of cortisol daily. A single sample was obtained from the second patient while he was febrile.
About 50 ml. of plasma was obtained in each instance. The plasma proteins were precipitated with absolute alcohol and centrifuged.' The protein precipitate was extracted three times with 60 ml. of n-butanol; the alcohol and butanol extracts were pooled and dried in a rotating vacuum evaporator. The extract was dissolved in 70 per cent methanol and partitioned three times with hexane. The methanol phase was then concentrated in vacuo to a volume of about 1.0 ml. and streaked onto Whatman No. 3MM paper, 47 centimeters in length and 10 centimeters wide for electrophoresis.
Electrophoresis was performed in 0.1 molar barbital buffer with 20 per cent alcohol by volume at pH 8.6 at 400 volts and 20 m.a. for four hours. Twenty microgram standards of tetrahydrocortisone glucuronide and androsterone sulfate were spotted adjacent to the streaked extract. The glucuronide standard moved 8.5 centimeters toward the anode and the sulfate moved 11.0 centimeters toward the anode. The sulfate bands were located by cutting off the strip and dipping into Zimmermann reagent.1' Glucuronide band was located by dipping the strip into triphenyltetrazolium chloride reagent."3 The glucuronide and sulfate bands were cut out from the paper and eluted with 70 per cent methanol at 36°C. with shaking for two hours. Nonconjugated steroids which remained at the origin were cut out and eluted with methanol: chloroform (1:1) for two hours at 36°.
Paper chromatography was performed using washed Whatman No. 1 paper which was cut into strips 4 cm. wide and 50 cm. long. Beakers were placed beneath the strips to collect the effluent flows. The nonconjugated steroids were initially chromatographed in a Bush B5 system, 50 per cent methanol: benzene' to separate reduced corticosteroids from the 19-carbon steroids. The latter, being less polar than the corticosteroids, were collected in a beaker and re-chromatographed in System I., benzene :Skellysolve C® :methanol :water (Bush B-3), 33:66:80 :20w, along with reference standards of androsterone, dehydroisoandrosterone, and etiocholanolone. The C-19 steroids were also identified by their mobility in a heptane: propylene glycol system." The glucuronide eluate was chromatographed in n-butyl acetate, n-butanol, 10 per cent acetic acid (80:20:100)," along with reference standards of tetrahydrocortisone glucuronide and tetrahydrocortisol glucuronide. The sulfate eluates from the electrophoresis were chromatographed in System 2, n-butyl acetate: n-butanol: 10 per cent formic acid (80:20:100) , with reference standards of etiocholanolone sulfate, dehydroisoandrosterone sulfate, and androsterone sulfate. The paper chromatograms were equilibrated for 12 to 16 hours and descending chromatography performed for 6 hours at 25 270 C.* The C-19 steroids were identified by their mobility characteristics after staining with Zimmermann reagent. The glucuronides separated by paper chromatography were measured by a micro-carbazole test in a Beckman DU spectrophotometer at a wave length of 530 miu.'
After the C-19 steroid obtained from patient M.K. was purified in the chromatographic systems 1 and 3 ( Fig. 2) , sublimation in vacuo was performed. The melting point of the crystalline material thus obtained was measured in a Fisher melting point apparatus.
Urine:
A 24-hour urine was collected from patient W.S. in the Yale-New Haven Medical Center when the patient was not on steroids, although he was having an attack of periodic fever. A second 24-hour urine was collected while the patient was afebrile, 8 weeks later. The urines were hydrolyzed with beef liver beta-glucuronidase, 300 units per ml. (Ketodase®*) at pH 4.5 (sodium acetate buffer) and 37°C. for 72 hours. At the end of the incubation period the urine was extracted continuously for 48 hours at pH 1 (sulfuric acid) with ether. The ether was washed with a solution of 5 per cent sodium hydroxide until pigment-free and then with water until neutral. The washings were added to the urine after having been neutralized with sulfuric acid. The urine was then boiled for 60 minutes and extracted three times manually with equal volumes of ether. The ether phase was washed as described above, combined with the first extract, and dried in vacuo. Traces of water were removed with benzene. The crude extract obtained in this fashion was chromatographed on an alumina column in the gradient elution system described by Lakshmanan 
There was less than 0.3 ug./100 ml. of the glucuronides of tetrahydrocortisone and tetrahydrocortisol in the plasma of W.S. during the febrile phase. The level of the total 17-ketosteroid sulfate was less than 2.0 ug. in the febrile plasma. Only one 17-ketosteroid was present, i.e., nonconjugated etiocholanolone as detected on chromatogram I (Fig. 1) . The sulfate region from the afebrile plasma of patient W.S., when chromotographed in System 2 (chromatogram II, Fig. 1 ), revealed three Zimmermann-reacting areas. The first was an unidentified polar compound. The other compounds had mobilities identical with those of the pure reference compounds, dehydroisoandrosterone sulfate (marked D) and androsterone sulfate (marked A). No unconjugated 17-ketosteroids were detectable in the plasma drawn during the afebrile phase.
There were no detectable 17-ketosteroid sulfates or glucuronides present in the plasma of M.K. while he was febrile. On paper chromatography, etiocholanolone was recovered from the nonconjugated steroid area of the electrophoretogram and identified in Systems 1 and 3 (chromatograms III and V, Fig. 2) . The crystalline material obtained by sublimation from the area corresponding to etiocholanolone on chromatogram V (Fig. 2) revealed a melting point of 149 to 1500 C. The sulfuric acid spectrum of this substance in a Cary recording spectrophotometer revealed one peak at 312 mu. This evidence conclusively identifies the compound as etiocholanolone. It is of interest to note that free (nonpyrogenice) androsterone was also detected.
Urine:
In the urine of W.S. obtained during the afebrile phase there were four major peaks: androsterone-2.36 mg., etiocholanolone-3.97 mg., 11-oxy 17-ketosteroids plus A\9-11-desoxy-17 ketosteroids-10.5 mg. Androsterone and etiocholanolone appeared in their characteristic position in the chromatography (Fig. 3) , and were identified by their spectra in H2SO4 and infrared spectrophotometry (Fig. 4) . The febrile urine of W.S. revealed one main peak consisting of etiocholanolone (3.2 mg. per 24 hours). A more polar compound (11-oxy-17-ketosteroid of undetermined nature) was also eluted. Figure 4 shows the fingerprint region of the infrared spectrum of the System 3-heptane, propylene glycol toms were absent. A somewhat similar situation has been reported in a 7-year-old boy with the adrenogenital syndrome by Gonzales and Gardner,7 who found elevated total plasma ketosteroids during peculiar periods of paroxysmal fever, flushing, and pain in the abdomen and head, chilly sensations, prostration, and vomiting.
The demonstration of nonconjugated etiocholanolone appears particularly significant in our patients since in normal individuals 17-ketosteroids Kappas, Hellman, Fukushima, and Gallagher"1 reported that the intramuscular injection of etiocholanolone to normal human volunteers produced shaking chills followed by muscular aches and pains, anorexia, sweating, headache, and fever as high as 1030 F. Leukocytosis with a shift to the left of the differential count also occurred. When smaller doses of * Dubrulle and Claeys' measured unconjugated 17-ketosteroids in plasma and found 7-28 ug/100 ml. of plasma in 16 normal adolescents between the ages of 14 and 17. This finding is contrary to our own observations and those reported by Clayton, Bongiovanni, and Papadatos' and Migeon and Plagerl' who found that the amount of unconjugated steroid in plasma to be insignificant or absent. This hypothesis is further supported by the observation that adrenocorticotropin aggravates the symptoms while corticosteroids such as cortisone or prednisone ameliorate them.
The fact that W.S. had a reduced ability to form 17-hydroxycorticoids and a tendency to excrete increased quantities of urinary 17-ketosteroids, at least at one time in his course, and that the symptoms were benefitted by cortisone treatment suggests that he may have a block in the synthesis of cortisol analogous to that seen in true adrenogenital patients such as have been described by Wilkins.' One might postulate that in this type of patient failure to hydroxylate the 21-carbon results ultimately in an overproduction of A4-androstene, 3, 17-dione which is reduced to etiocholanolone elsewhere in the body (presumably in the liver). This hypothesis seems unlikely for two reasons: first because in the ordinary adrenogenital patient no defect in 11-f3-hydroxylation occurs,'0 so that much of the excess of 17-ketosteroid is hydroxylated on the 11 carbon; this was not the case in our patients. Moreover, overproduction of etiocholanolone is not, in itself, associated with fever, since the conjugated form of the steroid may be excreted in large quantities without associated symptoms. It appears that a failure to conjugate the substance must also be present in order for symptoms to occur.
A more likely hypothesis, therefore, points to the liver as a possible source of the difficulty. The reduction of androgens normally results in the production of androsterone and etiocholanolone, which are promptly conjugated. Our patients may suffer from an episodic inability to conjugate the steroids, associated with an increased production of etiocholanolone in preference to androsterone as an end product of androgen reduction.
There is no definite evidence of hepatic disease in these patients, but the hepatic and splenic enlargement in W.S., associated with abnormal plasma protein patterns in both patients, suggests that other parameters of hepatic function may be disturbed.
Although etiocholanolone causes fever in human beings, it is not like bacterial "pyrogen" since no tolerance develops to its administration.' Moreover, etiocholanolone does not cause fever in rabbits." For these reasons it seems unlikely that etiocholanolone plays an important part in the development of ordinary fever in human beings.
SUMMARY
Unconjugated etiocholanolone has been demonstrated in the plasma of two patients suffering from periodic attacks of fever, malaise, nausea, and myalgia (periodic disease). The steroid was not present in the unconjugated form between attacks in one of the subjects. The only 17-keto-steroid present in measurable quantities in the urine of one patient during an attack was etiocholanolone, whereas between attacks a normal distribution of urinary 17-ketosteroids was present. The nature of the etiocholanolone was proven by chromatographic mobility characteristics, melting point, sulfuric acid spectrum (in plasma), and these plus infrared spectrum (in urine). It is proposed that the attacks of periodic fever in these patients are a result of the presence of unconjugated etiocholanolone in the plasma. Possible mechanisms for this abnormality are discussed.
